Pfizer’s CEO Albert Bourla has revamped sales tactics, leading to a 31% rise in U.S. sales of Nurtec migraine medication, reports The Wall Street Journal.
President Xi plans to meet with Qualcomm and Saudi Aramco CEOs following this year’s China Development Forum, according to ...
After learning doctors weren’t prescrbing its migraine drug Nurtec because they assumed insurance coverage would be a hassle, the company ...
The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...
In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing.
In Thursday's meeting, the director of the FDA's Center for Drug Evaluation and Research said plans for coming layoffs were ...
Portage already owned adjacent parcels to the north and south of the property, and holds an easement along the western edge ...
Pharma firms are among many pausing diversity programmes and promising domestic investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback